How big is the Preimplantation Genetic Testing Market | Size, Share & Analysis 2026

Code: MTA8166 Publication Date: Aug 2025

What is the Preimplantation Genetic Testing Market Size?

According to 6Wresearch internal database and industry insights, the Global Preimplantation Genetic Testing Market was valued at USD 2 billion in 2025 and is expected to reach USD 3 billion by 2032, growing at a CAGR of 5.90% during the forecast period of 2026-2032.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Preimplantation Genetic Testing Market.

The market is witnessing steady growth as awareness regarding genetic disorders and the benefits of early embryo screening rises globally. Rising demand for in-vitro fertilization (IVF), increasing maternal age, and mounting worries around genetic diseases are key contributors to market expansion. Moreover, high-tech advancements in genetic sequencing, improved embryo biopsy methods, and expanding access to fertility clinics are supporting the rising adoption of preimplantation genetic testing (PGT) services across regions.

Major Gro

  • wth Factors of the Preimplantation Genetic Testing Market
  • The market is rising over incidence of genetic and chromosomal disorders
  • There has been increasing demand for IVF and assisted reproductive technologies
  • Technological advancements in embryo screening and biopsy
  • Higher maternal age contributing to increased genetic risks
  • The market is growing awareness of hereditary diseases and prevention
  • Improved access to fertility care in developing regions
  • Supportive government regulations and ethical advancements in reproductive health
  • There has been increased availability of genetic counselling services

Preimplantation Genetic Testing Market Trends

The Preimplantation Genetic Testing Market is growing with a robust focus on accuracy medicine and customized reproductive health. Incorporation of next-generation sequencing (NGS) and artificial intelligence is enhancing the precision of embryo screening. There is a rising trend toward comprehensive chromosome screening (CCS) and non-invasive PGT methods. Customer demand for genetic transparency and healthier pregnancy outcomes is driving inventions in laboratory workflows and data analytics.

Emerging Developments in the Preimplantation Genetic Testing Market

The Preimplantation Genetic Testing market is emerging through innovations in non-invasive embryo analysis, single-cell genomics, and AI-driven embryo selection tools. Firms are investing in automating genetic testing platforms and enhancing lab efficiency. Extension of fertility tourism and partnerships between IVF clinics and genetic labs are increasing global market access. Governing developments are also improving standardization and ethical compliance in PGT services.

List of Leading Companies in the Preimplantation Genetic Testing Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Illumina, Inc.

Company NameIllumina, Inc.
Established Year1998
HeadquartersSan Diego, California, United States
Official WebsiteClick Here

Illumina develops preimplantation genetic testing solutions, offering high-quality, accurate, and innovative genomic sequencing and screening technologies to support embryo selection and IVF success worldwide.

2.Thermo Fisher Scientific Inc.

Company NameThermo Fisher Scientific Inc.
Established Year1956
HeadquartersWaltham, Massachusetts, United States
Official WebsiteClick Here

Thermo Fisher provides preimplantation genetic testing products and services, delivering high-quality, reliable, and advanced molecular diagnostics and genetic analysis solutions for IVF and reproductive health.

3.CooperSurgical, Inc.

Company NameCooperSurgical, Inc.
Established Year1990
HeadquartersTrumbull, Connecticut, United States
Official WebsiteClick Here

CooperSurgical offers PGT solutions, providing precise, high-quality, and innovative reproductive health products and services to support embryo selection and IVF success worldwide.

4. Fertility Genomics, Inc.

Company NameFertility Genomics, Inc.
Established Year2010
HeadquartersSan Diego, California, United States
Official WebsiteClick Here

Fertility Genomics manufactures preimplantation genetic testing products, offering high-quality, accurate, and reliable genomic screening solutions to optimize embryo selection and improve IVF outcomes.

5. Pacific Biosciences of California, Inc.

Company NamePacific Biosciences of California, Inc.
Established Year2004
HeadquartersMenlo Park, California, United States
Official WebsiteClick Here

Pacific Biosciences develops PGT solutions using advanced sequencing technologies, providing high-quality, accurate, and innovative genetic analysis tools for reproductive medicine and IVF worldwide.

6. Natera, Inc.

Company NameNatera, Inc.
Established Year2004
HeadquartersSan Carlos, California, United States
Official WebsiteClick Here

Natera provides preimplantation genetic testing and reproductive health solutions, delivering high-quality, precise, and reliable genomic screening technologies to support embryo selection.

7. PGT Laboratories (PGT Genetics)

Company NamePGT Laboratories (PGT Genetics)
Established Year2008
HeadquartersLos Angeles, California, United States
Official WebsiteClick Here

PGT Laboratories offers preimplantation genetic testing services, providing high-quality, accurate, and reliable embryo screening solutions for IVF clinics and reproductive specialists worldwide.

8.Genea Limited

Company NameGenea Limited
Established Year2004
HeadquartersSydney, Australia
Official WebsiteClick Here

Genea develops PGT solutions and reproductive health services, offering innovative, high-quality, and reliable genetic testing products to improve IVF success rates.

9. CoGenics, Inc.

Company NameCoGenics, Inc.
Established Year2012
HeadquartersSouth San Francisco, California, United States
Official WebsiteClick Here

CoGenics provides preimplantation genetic testing and reproductive genomics solutions, delivering high-quality, accurate, and reliable embryo screening technologies for fertility clinics worldwide.

10.Igenomix

Company NameIgenomix
Established Year2008
HeadquartersValencia, Spain
Official WebsiteClick Here

Igenomix offers preimplantation genetic testing and reproductive health solutions, providing high-quality, innovative, and precise genomic screening technologies to improve IVF outcomes for clinics and patients.

How big is the Preimplantation Genetic Testing Market : FAQ's

The Preimplantation Genetic Testing Market was projected to be valued at USD 2 billion in 2025 and reach around USD 3 billion by 2032.
The Preimplantation Genetic Testing Market is expected to grow at a CAGR of 5.90% during the forecast period.
Key trends include AI-assisted embryo selection, next-generation sequencing integration, non-invasive PGT techniques, and growing consumer demand for genetic transparency.
The Preimplantation Genetic Testing Market is driven by increasing use of IVF, rising genetic disorder awareness, technological advancements, and global access to fertility care.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All